Search | IOVS | ARVO Journals

Showing 1 – 20 of 174

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: First-Time Three-Year Results of the TRUCKEE Study

Hannah Khan; Aamir Abdul Aziz; Huma Khan; Ohidul Mojumder; Humza Sulahria; Greggory Gahn; Ashkan Michael Abbey; Emmanuel Chang; Giulia Corradetti; Carl Danzig; Sara Haug; SriniVas R Sadda; Veeral Sheth; Michael Andrew Singer; Jeremy Wolfe; Robert Wong; Arshad M. Khanani

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):717.

ARVO Annual Meeting Abstract June 2025

Mechanistic investigations of the pro-apoptotic effects of growth hormone-releasing hormone receptor antagonists MIA-602 on retinoblastoma

Jiahui LI; Linbin Zhou; Hoi Ying Emily Chan; Clement C. Tham; Jason C. Yam; Calvin C P Pang; WAI KIT CHU

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):22.

ARVO Annual Meeting Abstract June 2025

Evolution of Intra-arterial Chemotherapy and Globe Salvage Outcome in Retinoblastoma

nicha jarupanich; Supanat Thanomteeranant; Ratima Chokchaitanasin; Suradej Hongeng; Ekachat Chanthanaphak; Duangnate Rojanaporn

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):24.

ARVO Annual Meeting Abstract June 2025

Evaluation of a Novel Tunable Intensity Wavelength Solid State Light (SSL) Source in Vitreoretinal (VR) Diseases for Enhanced visualization and instrumentation

Emmanuel Chang; Brian McCary; Robert Mentzer; Charles Dranoff; Lester Hosten

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):260.

ARVO Annual Meeting Abstract June 2025

The growth hormone-releasing hormone receptor antagonist MIA-602 potentiates chemotherapy effects on retinoblastoma

Hoi Ying Emily Chan; Linbin Zhou; Jiahui Li; Clement C. Tham; Jason C. Yam; Calvin C P Pang; WAI KIT CHU

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):28.

ARVO Annual Meeting Abstract June 2025

The Safety on the Anterior Chamber and Lens of Vectored Thermal Pulsation and Intense Pulsed Light Treatment for Meibomian Gland Dysfunction

Kam-lung, Kelvin Chong; Zhichao Hu; Yiu Man Wong; Fatema Aljufairi; Hoi Ying Emily Chan

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):5681.

ARVO Annual Meeting Abstract June 2025

Appropriateness and Readability of ChatGPT-4-Generated Responses for Retinopathy of Prematurity

Kristine Y Wang; Bita Momenaei; Taku Wakabayashi; Emmanuel Chang; Eric Nudleman; Yoshihiro Yonekawa

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):OD106.

ARVO Annual Meeting Abstract June 2025

Faricimab for Coats Disease

Flavius Beca; Emmanuel Chang; Luis Acaba-Berrocal; Sami H Uwaydat; Yoshihiro Yonekawa

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4701.

ARVO Annual Meeting Abstract June 2025

Visual and Anatomic Outcomes in nAMD Patients with Subretinal Hemorrhage After Treatment with Faricimab in the TRUCKEE Study – First Time Results of Two-Year Data

Huma Khan; Hannah Khan; Aamir Abdul Aziz; Ohidul Mojumder; Greggory Gahn; Ashkan Michael Abbey; Robert L Avery; Himanshu K Banda; Mark Barakat; Ramanath Bhandari; Emmanuel Chang; Sara Haug; Nikolas J S London; Veeral Sheth; Jeremy Wolfe; Michael Andrew Singer; Carl Danzig; Arshad M. Khanani

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4106.

ARVO Annual Meeting Abstract June 2025

Altered retinal vascular morphology and distribution in experimental models of chronic HIV infection

Mostafa Mahrous; Sheila Fosca Ngumbi; Simone Kennard; Meghan Mcgee-Lawrence; Eric Belin De Chantemele; Manuela Bartoli

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):5879.

Retina April 2025

Fecal Microbial Profiles and Short-Chain Fatty Acid/Bile Acid Metabolomics in Patients With Age-Related Macular Degeneration: A Pilot Study

PDF

Zaid Parekh; Jason Xiao; Amir Mani; Quadis Evans; Christopher Phung; Hugo A. Barba; Bingqing Xie; Ashley M. Sidebottom; Anitha Sundararajan; Huaiying Lin; Ramanujam Ramaswamy; David Dao; Reem Gonnah; Madeleine Yehia; Seenu M. Hariprasad; Mark D'Souza; Dinanath Sulakhe; Eugene B. Chang; Dimitra Skondra
TAGS: age-related macular degeneration, bile acids, feces, metabolites, metabolomics, pilot projects, volatile fatty acids, cohort studies, microbiome, gastrointestinal microbiome
Invest. Ophthalmol. Vis. Sci.. 2025; 66(4):21. https://doi.org/10.1167/iovs.66.4.21

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Polygenic prediction of keratoconus and its measures: cross-sectional and longitudinal analyses in community-based young adults

Samantha Sze-Yee Lee; Santiago Diaz Torres; Weixiong He; Elsie Chan; Elaine Chong; Puya Gharahkhani; Stuart MacGregor; Gareth Lingham; David A Mackey

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2852.

ARVO Annual Meeting Abstract June 2024

Inhibitory Effects of 5Z-7-Oxozeaenol on TGFβ1-Induced Responses in Human Tenon’s Fibroblasts

Jennifer Fan Gaskin; Cheng Zeng; Roy Kong; Guei-Sheung Liu; Elsa Chan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5148.

ARVO Annual Meeting Abstract June 2024

Dual optical coherence tomography and microscopy for characterization of cystinosis in the cornea

Cristina Canavesi; Andrea Cogliati; Hayley E. Chang; Landa Prifti; Alexander G. Solorzano; Kuan Hong Wang; Ed G. Freedman; John J. Foxe

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):990.

ARVO Annual Meeting Abstract June 2024

Analysis of Artificial Tear Effects on Objective Noninvasive Dry Eye Parameters

Emily R White; Nicholas Fazio; Andre Galenchik-Chan; Lauren Langman; Ken Reed; Sarah Weissbart; Timothy Chou; Konstantinos Tourmouzis; Eileen Chang; Robert A Honkanen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6547.

ARVO Annual Meeting Abstract June 2024

Pigment-Epithelium-Derived-Factor Derived Short Peptide Promotes Cell Proliferation and Wound Healing

Luis Alberto Rodríguez; Yalang Huang; Erin Chang; Frank Lee; Victor L Perez; Wen Chyi Shyu

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):61.

ARVO Annual Meeting Abstract June 2024

Evaluating Prevalence of Dry Eye in a Glaucoma Clinic at Stony Brook

Cartomou Feseru; Simatul Rashid; Lauren Telesca; Sarah Weissbart; Sarah Wellik; Sunita Radhakrishan; Kevin Kaplowitz; Ishan Amin Khwaja; Eileen Chang; Nga Yan Siu; Timothy Chou; Robert A Honkanen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1878.

ARVO Annual Meeting Abstract June 2024

Outcomes of using the Biovance® 3L Ocular Human Amniotic Membrane Allograft for corneal epithelial defects

Enchi Chang; Nandini Venkateswaran

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):30.

ARVO Annual Meeting Abstract June 2024

Retinal vascularisation rate predicts retinopathy of prematurity (ROP) and remains unaffected by anti-VEGF therapy

Emer Chang; Amandeep Singh Josan; Ravi S Purohit; Sher A Aslam; Caroline Hartley; Kanmin Xue

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1711.

ARVO Annual Meeting Abstract June 2024

The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study - 2 Year Results

Aamir Abdul Aziz; Hannah Khan; Mark Rami Barakat; Ramanath Bhandari; Emmanuel Chang; Giulia Corradetti; Carl J Danzig; Jordan M Graff; Nikolas JS London; Jared Nielsen; Veeral Sheth; Jeremy Wolfe; Robert William Wong; SriniVas R Sadda; Michael Andrew Singer; Arshad M. Khanani

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2789.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: First-Time Three-Year Results of the TRUCKEE Study

Mechanistic investigations of the pro-apoptotic effects of growth hormone-releasing hormone receptor antagonists MIA-602 on retinoblastoma

Evolution of Intra-arterial Chemotherapy and Globe Salvage Outcome in Retinoblastoma

Evaluation of a Novel Tunable Intensity Wavelength Solid State Light (SSL) Source in Vitreoretinal (VR) Diseases for Enhanced visualization and instrumentation

The growth hormone-releasing hormone receptor antagonist MIA-602 potentiates chemotherapy effects on retinoblastoma

The Safety on the Anterior Chamber and Lens of Vectored Thermal Pulsation and Intense Pulsed Light Treatment for Meibomian Gland Dysfunction

Appropriateness and Readability of ChatGPT-4-Generated Responses for Retinopathy of Prematurity

Faricimab for Coats Disease

Visual and Anatomic Outcomes in nAMD Patients with Subretinal Hemorrhage After Treatment with Faricimab in the TRUCKEE Study – First Time Results of Two-Year Data

Altered retinal vascular morphology and distribution in experimental models of chronic HIV infection

Fecal Microbial Profiles and Short-Chain Fatty Acid/Bile Acid Metabolomics in Patients With Age-Related Macular Degeneration: A Pilot Study

Polygenic prediction of keratoconus and its measures: cross-sectional and longitudinal analyses in community-based young adults

Inhibitory Effects of 5Z-7-Oxozeaenol on TGFβ1-Induced Responses in Human Tenon’s Fibroblasts

Dual optical coherence tomography and microscopy for characterization of cystinosis in the cornea

Analysis of Artificial Tear Effects on Objective Noninvasive Dry Eye Parameters

Pigment-Epithelium-Derived-Factor Derived Short Peptide Promotes Cell Proliferation and Wound Healing

Evaluating Prevalence of Dry Eye in a Glaucoma Clinic at Stony Brook

Outcomes of using the Biovance® 3L Ocular Human Amniotic Membrane Allograft for corneal epithelial defects

Retinal vascularisation rate predicts retinopathy of prematurity (ROP) and remains unaffected by anti-VEGF therapy

The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study - 2 Year Results

To View More...

You must be signed into an individual account to use this feature.